Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Actelion Acquires CoTherix For $420 mil.

Nov 20 2006

• By Daniel Fowler

Related Content

Revatio Labeling Includes Warning On “Visual Disturbances”

Jun 06 2005

CoTherix’ Ventavis Cleared For Combination Use

Aug 30 2005

Roche, Actelion To Develop S1P1 Receptor Agonist For Autoimmune Disease

Jul 17 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window